Observational studyJAMA ophthalmology2021

Insights From Survival Analyses During 12 Years of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration.

Dun Jack Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.